Viatris (VIA) Stock Forecast & Price Target

Compare

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VIA Analyst Ratings

Hold

1 Buy

2 Hold

1 Sell

Based on 4 analysts giving stock ratings to

Viatris

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VIA Stock 12 Month Forecast

Average Price Target

€10.03

▲(6.35% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for Viatris in the last 3 months. The average price target is €10.03 with a high forecast of €12.03 and a low forecast of €7.73. The average price target represents a 6.35% change from the last price of €9.43.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","13":"€13","7.75":"€7.75","9.5":"€9.5","11.25":"€11.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12.03061272,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€12.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.0283750316,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€10.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.73396532,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€7.73</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,7.75,9.5,11.25,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.926,9.164816363076923,9.403632726153846,9.64244908923077,9.881265452307693,10.120081815384616,10.358898178461539,10.597714541538462,10.836530904615385,11.075347267692308,11.314163630769231,11.552979993846154,11.791796356923077,{"y":12.03061272,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.926,9.010798079353846,9.095596158707693,9.180394238061538,9.265192317415385,9.34999039676923,9.434788476123076,9.519586555476923,9.604384634830769,9.689182714184614,9.773980793538461,9.858778872892307,9.943576952246154,{"y":10.0283750316,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.926,8.834305024615384,8.74261004923077,8.650915073846154,8.55922009846154,8.467525123076923,8.375830147692309,8.284135172307693,8.192440196923076,8.100745221538462,8.009050246153846,7.917355270769231,7.8256602953846155,{"y":7.73396532,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.13,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.922,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.303,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":10.347,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.468,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.762,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.124,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":7.436,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.47,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.434,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.716,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.562,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.926,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€12.03

Average Price Target€10.03

Lowest Price Target€7.73

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Les Sulewski

Truist Financial

―

Buy

―

Reiterated

11/07/25

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (NASDAQ: BIOA), Astrana Health (NASDAQ: ASTH) and Viatris (NASDAQ: VTRS)

Jason Gerberry

Bank of America Securities

€6.87→€7.73

Sell

-17.99%

Downside

Reiterated

11/06/25

Bank of America Securities Remains a Sell on Viatris (VTRS)

Matthew Dellatorre

Goldman Sachs

€9.45→€10.31

Hold

9.35%

Upside

Reiterated

10/22/25

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Viatris (NASDAQ: VTRS)

Unknown Analyst

J.P. Morgan

Not Ranked

J.P. Morgan

€12.03

Hold

27.58%

Upside

Reiterated

09/16/25

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)

David Amsellem

Piper Sandler

€7.73

Hold

-17.99%

Downside

Reiterated

08/29/25

Piper Sandler Keeps Their Hold Rating on Viatris (VTRS)

Glen Santangelo

Jefferies

€12.89→€11.17

Buy

18.47%

Upside

Reiterated

03/07/25

Viatris price target lowered to $13 from $15 at JefferiesViatris price target lowered to $13 from $15 at Jefferies

Balaji Prasad

Barclays

€10.31

Sell

9.35%

Upside

Reiterated

02/27/25

Barclays Remains a Sell on Viatris (VTRS)

Jasper Hellweg

Argus Research

―

Hold

―

Reiterated

01/06/25

Argus Research Keeps Their Hold Rating on Viatris (VTRS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Les Sulewski

Truist Financial

―

Buy

―

Reiterated

11/07/25

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (NASDAQ: BIOA), Astrana Health (NASDAQ: ASTH) and Viatris (NASDAQ: VTRS)

Jason Gerberry

Bank of America Securities

€6.87→€7.73

Sell

-17.99%

Downside

Reiterated

11/06/25

Bank of America Securities Remains a Sell on Viatris (VTRS)

Matthew Dellatorre

Goldman Sachs

€9.45→€10.31

Hold

9.35%

Upside

Reiterated

10/22/25

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Viatris (NASDAQ: VTRS)

Unknown Analyst

J.P. Morgan

Not Ranked

J.P. Morgan

€12.03

Hold

27.58%

Upside

Reiterated

09/16/25

J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)

David Amsellem

Piper Sandler

€7.73

Hold

-17.99%

Downside

Reiterated

08/29/25

Piper Sandler Keeps Their Hold Rating on Viatris (VTRS)

Glen Santangelo

Jefferies

€12.89→€11.17

Buy

18.47%

Upside

Reiterated

03/07/25

Viatris price target lowered to $13 from $15 at JefferiesViatris price target lowered to $13 from $15 at Jefferies

Balaji Prasad

Barclays

€10.31

Sell

9.35%

Upside

Reiterated

02/27/25

Barclays Remains a Sell on Viatris (VTRS)

Jasper Hellweg

Argus Research

―

Hold

―

Reiterated

01/06/25

Argus Research Keeps Their Hold Rating on Viatris (VTRS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Viatris

1 Month

xxx

Success Rate

11/20 ratings generated profit

Average Return

+0.27%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.00% of your transactions generating a profit, with an average return of +0.27% per trade.

3 Months

xxx

Success Rate

13/20 ratings generated profit

Average Return

+4.82%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +4.82% per trade.

1 Year

Balaji PrasadBarclays

Success Rate

8/20 ratings generated profit

Average Return

-5.03%

reiterated a sell rating 9 months ago

Copying Balaji Prasad's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -5.03% per trade.

2 Years

xxx

Success Rate

10/20 ratings generated profit

Average Return

-8.02%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -8.02% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VIA Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VIA has received 2 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. VIA average Analyst price target in the past 3 months is 10.03.

Each month's total comprises the sum of three months' worth of ratings.

VIA Financial Forecast

VIA Earnings Forecast

Next quarter’s earnings estimate for VIA is €0.46 with a range of €0.44 to €0.50. The previous quarter’s EPS was €0.58. VIA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Sales Forecast

Next quarter’s sales forecast for VIA is €3.04B with a range of €2.95B to €3.12B. The previous quarter’s sales results were €3.23B. VIA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year VIA has Performed in-line its overall industry.

VIA Stock Forecast FAQ

What is DE:VIA’s average 12-month price target, according to analysts?

Based on analyst ratings, Viatris’s 12-month average price target is 10.03.

What is DE:VIA’s upside potential, based on the analysts’ average price target?

Viatris has 6.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Viatris a Buy, Sell or Hold?

Viatris has a consensus rating of Hold, which is based on 1 buy ratings, 2 hold ratings and 1 sell ratings.

What is Viatris’s share price target?

The average share price target for Viatris is 10.03. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €12.03 ,and the lowest forecast is €7.73. The average share price target represents 6.35% Increase from the current price of €9.43.

What do analysts say about Viatris?

Viatris’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of Viatris?

To buy shares of DE:VIA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Viatris (VIA) Stock Forecast & Price Target

VIA Analyst Ratings

VIA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Viatris

VIA Analyst Recommendation Trends

VIA Financial Forecast

VIA Earnings Forecast

VIA Sales Forecast

VIA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts